Literature DB >> 24371776

Regression of a case of Multiple Myeloma with antiviral treatment in a patient with chronic HCV infection.

Sara Panfilio1, Pasqualina D'Urso1, Giorgia Annechini1, Gianna Maria D'Elia1, Federico De Angelis1, Caterina Stefanizzi1, Alessandro Pulsoni1.   

Abstract

We report a case of a 54 year old patient with Multiple Myeloma (MM) and chronic HCV infection. In 2005 MM was diagnosed and a chemotherapy was prescribed. Before starting treatment a chronic HCV infection was found. When she came to our Institution for a second opinion, chemotherapy treatment was not considered immediately necessary so the patient was treated for the HCV chronic infection (Pegilated alpha-Interferon 180 μg/week and Ribavirin 1000 mg p.o./day). After one month of treatment she presented a reduction of Bence Jones protein (BJ) that further decreased in the following three months. The antiviral treatment was suspended after six months and a re-evaluation showed a complete viral response and a regression of MM. Sixty-eight months after the end of antiviral treatment the patient is asymptomatic and presents a condition compatible with an M-GUS. While the association between HCV infection and non-Hodgkin's lymphoma is consolidated and it is clearly demonstrated that antiviral treatment in these patients can induce a high proportion of partial and complete remission, a similar effect was never described in MM. The response obtained in our patient may suggest a possible a role of HCV in the pathogenesis of MM.

Entities:  

Keywords:  HCV; Hepatitis; Myeloma; Treatment

Year:  2013        PMID: 24371776      PMCID: PMC3850378          DOI: 10.1016/j.lrr.2013.01.002

Source DB:  PubMed          Journal:  Leuk Res Rep        ISSN: 2213-0489


  7 in total

1.  Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience.

Authors:  Daniele Vallisa; Patrizia Bernuzzi; Luca Arcaini; Stefano Sacchi; Vittorio Callea; Roberto Marasca; Antonio Lazzaro; Elena Trabacchi; Elisa Anselmi; Anna Lisa Arcari; Carlo Moroni; Raffaella Bertè; Mario Lazzarino; Luigi Cavanna
Journal:  J Clin Oncol       Date:  2005-01-20       Impact factor: 44.544

2.  Interferon-alpha treatment in multiple myeloma: meta-analysis of 30 randomised trials among 3948 patients.

Authors:  E Fritz; H Ludwig
Journal:  Ann Oncol       Date:  2000-11       Impact factor: 32.976

Review 3.  Interferon-alpha in the treatment of multiple myeloma.

Authors:  Teh Liane Khoo; Annette Juul Vangsted; Douglas Joshua; John Gibson
Journal:  Curr Drug Targets       Date:  2011-03-01       Impact factor: 3.465

4.  Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study.

Authors:  Alfonso Mele; Alessandro Pulsoni; Elvira Bianco; Pellegrino Musto; Andre Szklo; Maria Grazia Sanpaolo; Emilio Iannitto; Amalia De Renzo; Bruno Martino; Vincenzo Liso; Cristina Andrizzi; Simona Pusterla; Fausto Dore; Maddalena Maresca; Maria Rapicetta; Fabrizio Marcucci; Franco Mandelli; Silvia Franceschi
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

5.  Hematopoietic malignancies associated with viral and alcoholic hepatitis.

Authors:  Lesley A Anderson; Ruth Pfeiffer; Joan L Warren; Ola Landgren; Shahinaz Gadalla; Sonja I Berndt; Winnie Ricker; Ruth Parsons; William Wheeler; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10-28       Impact factor: 4.254

6.  Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.

Authors:  Elvira Bianco; Fabrizio Marcucci; Alfonso Mele; Pellegrino Musto; Rodolfo Cotichini; Maria Grazia Sanpaolo; Emilio Iannitto; Amalia De Renzo; Bruno Martino; Giorgina Specchia; Marco Montanaro; Anna Maria Barbui; Rosa Nieddu; Livio Pagano; Maria Rapicetta; Silvia Franceschi; Franco Mandelli; Alessandro Pulsoni
Journal:  Haematologica       Date:  2004-01       Impact factor: 9.941

7.  Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.

Authors:  Olivier Hermine; François Lefrère; Jean-Pierre Bronowicki; Xavier Mariette; Katayoun Jondeau; Virginie Eclache-Saudreau; Béatrice Delmas; Françoise Valensi; Patrice Cacoub; Christian Brechot; Bruno Varet; Xavier Troussard
Journal:  N Engl J Med       Date:  2002-07-11       Impact factor: 91.245

  7 in total
  8 in total

1.  Monoclonal IgG in MGUS and multiple myeloma targets infectious pathogens.

Authors:  Adrien Bosseboeuf; Delphine Feron; Anne Tallet; Cédric Rossi; Cathy Charlier; Laurent Garderet; Denis Caillot; Philippe Moreau; Marina Cardó-Vila; Renata Pasqualini; Wadih Arap; Alfreda Destea Nelson; Bridget S Wilson; Hélène Perreault; Eric Piver; Pierre Weigel; François Girodon; Jean Harb; Edith Bigot-Corbel; Sylvie Hermouet
Journal:  JCI Insight       Date:  2017-10-05

2.  Characteristics of MGUS and Multiple Myeloma According to the Target of Monoclonal Immunoglobulins, Glucosylsphingosine, or Epstein-Barr Virus EBNA-1.

Authors:  Adrien Bosseboeuf; Nicolas Mennesson; Sophie Allain-Maillet; Anne Tallet; Eric Piver; Olivier Decaux; Caroline Moreau; Philippe Moreau; Philippe Lehours; Francis Mégraud; Valéry Salle; Edith Bigot-Corbel; Jean Harb; Sylvie Hermouet
Journal:  Cancers (Basel)       Date:  2020-05-15       Impact factor: 6.639

3.  Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including Myeloma.

Authors:  Alba Rodríguez-García; María Linares; María Luz Morales; Sophie Allain-Maillet; Nicolas Mennesson; Ricardo Sanchez; Rafael Alonso; Alejandra Leivas; Alfredo Pérez-Rivilla; Edith Bigot-Corbel; Sylvie Hermouet; Joaquín Martínez-López
Journal:  Front Immunol       Date:  2022-01-11       Impact factor: 7.561

Review 4.  The Role of the Crosstalk Between Gut Microbiota and Immune Cells in the Pathogenesis and Treatment of Multiple Myeloma.

Authors:  Marcin Jasiński; Jarosław Biliński; Grzegorz W Basak
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

5.  Editorial: The Role of Microorganisms in Multiple Myeloma.

Authors:  Maria Linares; Sylvie Hermouet
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 6.  Pathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic Inflammation.

Authors:  Sylvie Hermouet; Edith Bigot-Corbel; Betty Gardie
Journal:  Mediators Inflamm       Date:  2015-10-11       Impact factor: 4.711

7.  Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients.

Authors:  Adrien Bosseboeuf; Célia Seillier; Nicolas Mennesson; Sophie Allain-Maillet; Maeva Fourny; Anne Tallet; Eric Piver; Philippe Lehours; Francis Mégraud; Laureline Berthelot; Jean Harb; Edith Bigot-Corbel; Sylvie Hermouet
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

8.  Editorial: Structure, Isotypes, Targets, and Post-translational Modifications of Immunoglobulins and Their Role in Infection, Inflammation and Autoimmunity.

Authors:  Jean Harb; Bridget S Wilson; Sylvie Hermouet
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.